×
Sol-Gel Technologies SG&A Expenses 2016-2024 | SLGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sol-Gel Technologies sg&a expenses from 2016 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
Sol-Gel Technologies SG&A Expenses 2016-2024 | SLGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sol-Gel Technologies sg&a expenses from 2016 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19B
Dr Reddy's Laboratories (RDY)
$12B
BridgeBio Pharma (BBIO)
$4.3B
Bausch Health Cos (BHC)
$3B
Amphastar Pharmaceuticals (AMPH)
$2.1B
Supernus Pharmaceuticals (SUPN)
$2B
Taysha Gene Therapies (TSHA)
$434M
Personalis (PSNL)
$261M
Assembly Biosciences (ASMB)
$98M
Evoke Pharma (EVOK)
$7M
Teligent (TLGT)
$0M